3-溴-4-乙氧基-5-甲氧基苯甲醛 | 90109-65-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴-4-乙氧基-5-甲氧基苯甲醛
• 英文名称: 3-bromo-4-ethoxy-5-methoxybenzaldehyde
• CAS: 90109-65-2
• 化学式: C₁₀H₁₁BrO₃
• mdl: MFCD02256495
• 分子量: 259.1
• InChiKey: UYORHVZNGJVQCF-UHFFFAOYSA-N

物化性质

• 沸点：
  327.6±37.0 °C(Predicted)
• 密度：
  1.425±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2913000090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 3-Bromo-4-Ethoxy-5-Methoxybenzaldehyde
: OTV000072
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

---

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 259,1 g/mol
No components need to be disclosed according to the applicable regulations.

---

SECTION 4: First aid measures
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapours, mist or gas.
For personal protection see section 8.
Environmental precautions
No special environmental precautions required.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
No special environmental precautions required.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

---

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴-4-乙氧基-5-甲氧基苯甲醛 在 二异丁基氢化铝 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 4.0h， 生成 3-(3-Bromo-4-ethoxy-5-methoxyphenyl)prop-2-en-1-ol
  参考文献：
  名称：

  Synthesis of Some Phenylpropanoid Glycosides (PPGs) and Their Acetylcholinesterase/Xanthine Oxidase Inhibitory Activities

  摘要：

  在这项研究中，设计和合成了三类苯丙素糖苷（PPGs），以从红景天中分离的PPGs作为先导化合物。同时测试了它们对乙酰胆碱酯酶（AChE）和黄嘌呤氧化酶（XOD）的抑制能力。部分合成PPGs表现出了优异的酶抑制能力。

  DOI：

  10.3390/molecules16053580
• 作为产物：
  描述：

  香草醛 在 溴 、 potassium carbonate 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.08h， 生成 3-溴-4-乙氧基-5-甲氧基苯甲醛
  参考文献：
  名称：

  Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study

  摘要：

  In order to develop novel anti-cancer agents, a series of asymmetrical 2,6-bis (benzylidene)cyclohexanone derivatives containing nitrobenzylidene moiety were synthesized and their cytotoxic activity were determined in vitro against MDA-MB 231, MCF-7 and SK-N-MC cell lines using MTT assay. Among the tested compounds, the highest activity against MDA-MB 231 cells was achieved by 2-(3-bromo-5-methoxy-4-propoxybenzylidene)-6-(2-nitrobenzylidene)cyclohexanone (compound 5d). Whereas, compound 5j (the 3-nitro analog of compound 5d) was the most potent compound against MCF-7 and SK-N-MC cell lines. The results indicated that the cytotoxic activity profile against different tumor cells can be optimized by desired 4-alkoxy-3-bromo-5-methoxybenzylidene scaffold. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.01.045
• 作为试剂：
  描述：

  5-溴香兰素 、 Dicaesio carbonate 、 溴乙烷 、 水 在 乙醚 、 水 、 Brine 、 magnesium sulfate 、 3-溴-4-乙氧基-5-甲氧基苯甲醛 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 以3-bromo-4-ethoxy-5-methoxybenzaldehyde ANP 36050 (1.09 g, 97% yield) was obtained as a white solid的产率得到3-溴-4-乙氧基-5-甲氧基苯甲醛
  参考文献：
  名称：

  SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS

  摘要：

  本发明涉及替代异喹啉及其作为微管聚合抑制剂的用途。具体而言，本发明涉及具有有用治疗活性的替代异喹啉，这些化合物在治疗方法中的使用以及制药和含有这些化合物的组合物的制造。

  公开号：

  US20130131018A1

文献信息

• [EN] SUBSTITUTED ISOQUINOLINES AND THEIR USE AS TUBULIN POLYMERIZATION INHIBITORS<br/>[FR] ISOQUINOLÉINES SUBSTITUÉES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE POLYMÉRISATION DES TUBULINES
  申请人：EXONHIT S A

  公开号：WO2011151423A1

  公开（公告）日：2011-12-08

  The present invention relates generally to substituted isoquinolines and their use as tubulin polymerization inhibitors. In particular, the invention relates to substituted isoquinolines which possess useful therapeutic activity, use of these compounds in methods of therapy and the manufacture of medicaments as well as compositions containing these compounds.

  本发明总体上涉及取代异喹啉及其作为微管蛋白聚合抑制剂的应用。特别是，本发明涉及具有有用的治疗活性的取代异喹啉，这些化合物在治疗方法、药物制造以及含有这些化合物的组合物中的应用。
• Sulfur analogs of psychotomimetic agents. 30. Ethyl homologs of mescaline and their monothioanalogs
  作者：Peyton Jacob、Alexander T. Shulgin

  DOI：10.1021/jm00373a013

  日期：1984.7

  monothio analogues of the mono-, di-, and triethoxy homologues of mescaline have been synthesized and pharmacologically evaluated in man. Modifications at the ring position para to the ethylamine chain, either with a sulfur atom, a longer alkyl chain, or both, lead to compounds of high central nervous system activity. The 4-n-propoxy and 4-n-butoxy homologues and their corresponding 4-thio analogues were

  合成了麦斯卡林单，二和三乙氧基同系物的所有可能的单硫代类似物，并在人体中进行了药理学评估。在乙胺链对位的环位置进行的修饰，无论是被硫原子，更长的烷基链，还是两者都被修饰，都会导致中枢神经系统活性高的化合物。还合成了4-正丙氧基和4-正丁氧基同系物及其相应的4-硫代类似物，并进行了药理学评价。丙基同系物保留了高效力，但是丁基（具有或不具有硫原子）导致活性降低。间乙基或间硫代类似物保留一些中心作用，但是二乙氧基，尤其是三乙氧基同系物作为拟精神病药物相对无效。
• N-Methyl Pyrazoles
  申请人：Prosetta Antiviral, Inc.

  公开号：US20180118679A1

  公开（公告）日：2018-05-03

  This invention provides, among other things, compounds useful for treating viral infections, pharmaceutical formulations containing such compounds, as well as methods of inhibiting the replication of a virus or treating a disease.

  这项发明提供了用于治疗病毒感染的化合物，含有这种化合物的药物配方，以及抑制病毒复制或治疗疾病的方法等内容。
• Structural simplification of bioactive natural products with multicomponent synthesis: Dihydropyridopyrazole analogues of podophyllotoxin
  作者：Igor V. Magedov、Madhuri Manpadi、Elena Rozhkova、Nikolai M. Przheval’skii、Snezna Rogelj、Scott T. Shors、Wim F.A. Steelant、Severine Van slambrouck、Alexander Kornienko

  DOI：10.1016/j.bmcl.2006.11.095

  日期：2007.3

  aliphatic aldehydes leads to the formation of dihydropyridopyrazole analogues of a cytotoxic lignan podophyllotoxin. This new heterocyclic scaffold-based library allows a drastic reduction of the structural complexity of the natural product with the retention of its potent cytotoxic properties. Similarly to podophyllotoxin, the presented analogues induce apoptosis in Jurkat cells.

  5-氨基-3-甲基吡唑，tetronic酸和各种芳香族，杂芳香族和脂肪族醛的三组分缩合导致细胞毒性木脂多糖鬼臼毒素的二氢吡啶并吡唑类似物的形成。这个新的基于杂环支架的文库可以大大降低天然产物的结构复杂性，并保留其有效的细胞毒性。与鬼臼毒素相似，提出的类似物诱导Jurkat细胞凋亡。
• A New Naphthopyran Derivative Combines <i>c</i>-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties
  作者：Leonhard H. F. Köhler、Sebastian Reich、Maria Yusenko、Karl-Heinz Klempnauer、Amin H. Shaikh、Khursheed Ahmed、Gerrit Begemann、Rainer Schobert、Bernhard Biersack

  DOI：10.1021/acsmedchemlett.2c00403

  日期：2022.11.10

  three-component reaction of 1-naphthol, and various aryl aldehydes and malononitrile and screened for their c-Myb inhibitory activities. 1b also served as a lead compound for seven new naphthopyran derivatives (3a–f), which were cytotoxic with nanomolar IC50 values, to inhibit the polymerization of tubulin, and to destabilize microtubules in living cells. Especially, the alkyne 3f, originally made for

  基于有前途的c -Myb抑制剂1b，一系列2-氨基-4-芳基-4H-萘并[1,2- b ]吡喃-3-甲腈（1a，2a - q，3a - g）被重新利用或通过1-萘酚、各种芳基醛和丙二腈的三组分反应新合成并筛选其c -Myb抑制活性。1b还充当七种新型萘并吡喃衍生物 ( 3a – f ) 的先导化合物，这些衍生物具有纳摩尔 IC 50值的细胞毒性，可抑制微管蛋白的聚合，并使活细胞中的微管不稳定。特别是，最初使用点击化学进行细胞内定位研究的炔3f在所有进行的测定中都显示出整体高活性。检测到强烈的 G2/M 细胞周期停滞，通过效应器 caspase 3 和 7 的诱导，导致亚 G1 细胞明显增加。在体外和体内均证实了血管生成的抑制作用。总之，3f被发现是一种对癌细胞具有高选择性的多效性化合物，结合了c- Myb抑制、微管不稳定和抗血管生成作用。